The European Medicines Evaluation Annual

One of the factors that led to this publication is the setting up of the European Medicines Evaluation Agency, but the publication covers much more than that organization, and covers more than Europe. The organization that publishes the annual is independent of the agency, and therefore is able to be critical. The first section deals with the agency, its operation and its efficiency. The next two sections are on filing a European Patent, and the Patent Co‐operation Treaty. Labelling and packaging are considered next. The United States Food and Drugs Administration and filing US patents follow. The International Conference on...